LONDON—Europe’s medicines regulator has backed using AstraZeneca’s preventative COVID-19 therapy as a treatment for the disease and also endorsed another medicine as preventative option for another common virus.
The regulator’s recommendations are usually followed by the European Commission when it takes a final decision on drug approvals.
